An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna in advanced prostate cancer. Elsewhere, U.K. regulators cleared Sarepta to restart an Elevidys study and Altos Labs ...

A link to the live and archived webcasts may be accessed on the Unicycive website under the Investors section: Events and ...

Altos Labs, backed by $3 billion from Jeff Bezos and others, has snagged a small Peninsula company focused on one approach to stopping aging ...

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) (“Unicycive” or the “Company”), a clinical stage biotechnology company developing ...

Altos, led by industry stalwarts Hal Barron and Hans Bishop, brought Dorian Therapeutics into its fold this week, according ...

Bellarmine will visit Valley Christian for WCAL tournament title on Thursday. Los Altos’ Sly Cash pitches no-hitter against ...

New Drug Application (NDA) for hyperphosphatemia in chronic kidney disease patients on dialysis under review by FDA with PDUFA target action date of June 28, 2025; ongoing ...

LOS ALTOS PARK HAS UNDERGONE JUST A STUNNING TRANSFORMATION. YOU DRIVE BY THAT THING, IT’S BEAUTIFUL. PEYTON SPELLACY IS LIVE WITH MORE ON THE WORK DONE. HEY, PEYTON. HEY. GOOD MORNING ...

NewLimit, a biotechnology startup co-founded by Coinbase CEO Brian ... Amazon founder Jeff Bezos has thrown his weight behind another venture, Altos Labs, aiming to “reverse disease, injury, and the ...

But today, Kendall has been reborn — as the glittering, glassy heart of America’s biotech industry. For many companies, Kendall Square’s status as a global center of biotechnology firms and ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Hana El-Samad, PhD, is the senior vp of Altos Labs and Editor-in-Chief of GEN Biotechnology; Martin Borch Jensen is president of the non-profit Norn Group and founder and CSO of Gordian Biotechnology.